Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
34.74
-0.05 (-0.14%)
May 8, 2026, 4:00 PM EDT - Market closed
Cogent Biosciences Employees
Cogent Biosciences had 258 employees as of December 31, 2025. The number of employees increased by 53 or 25.85% compared to the previous year.
Employees
258
Change (1Y)
53
Growth (1Y)
25.85%
Revenue / Employee
n/a
Profits / Employee
-$1,373,267
Market Cap
5.94B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 258 | 53 | 25.85% |
| Dec 31, 2024 | 205 | 41 | 25.00% |
| Dec 31, 2023 | 164 | 26 | 18.84% |
| Dec 31, 2022 | 138 | 61 | 79.22% |
| Sep 30, 2022 | 121 | 44 | 57.14% |
| Dec 31, 2021 | 77 | 62 | 413.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Corcept Therapeutics | 730 |
| TG Therapeutics | 399 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Celcuity | 155 |
| CG Oncology | 142 |
COGT News
- 2 days ago - Cogent Biosciences price target raised to $55 from $52 at H.C. Wainwright - TheFly
- 4 days ago - Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results - GlobeNewsWire
- 18 days ago - Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 22 days ago - Cogent Biosciences announces preclinical data from KRAS, ErbB2 programs - TheFly
- 22 days ago - Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 5 weeks ago - Cogent Biosciences submits bezuclastinib new drug application to the FDA - TheFly
- 5 weeks ago - Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST) - GlobeNewsWire
- 7 weeks ago - Cogent Biosciences assumed with a Buy at Jefferies - TheFly